Financial news in brief: Avecho CBD trial latest; Argent’s milestone delivery – Cannabiz
Pharmaceutical CBD clinical trial development represents important progress in cannabis therapeutics, though patients should maintain realistic expectations about timing and superiority over current protocols. Understanding the distinction between…
Vaping cannabis cuts harmful toxins by 99% compared to smoking, study finds – leafie
New research demonstrates that cannabis vaporization reduces toxins by 99% compared to smoking, offering significant harm reduction benefits for medical cannabis patients. This evidence-based approach to consumption method selection can meaningfully…
Cannabis Medicines Show Modest Promise for Nerve Pain, But Evidence Remains Inconclusive
Cannabis medicines neuropathic pain evidence suggests potential benefits for nerve pain relief. However, study limitations like small samples and short durations hinder firm conclusions. More rigorous trials are needed to clarify efficacy and safety.
An Investigation of Cannabis and Mood: Online Study for Class Project ($25 Raffle)
This page discusses academic cannabis research recruitment focusing on a mood study conducted as a class project. The study uses social media platforms like Reddit for participant recruitment. Academic cannabis research recruitment is a growing trend in…
Is There a Place for Cannabis in Your Migraine Toolkit? A Recent Study Found That
Migraine affects over 1 billion people worldwide, prompting interest in cannabis efficacy for migraine relief. Recent studies explore cannabis as a potential tool in migraine management. Understanding the evidence helps patients and clinicians make…
Medical Cannabis for Orthopaedic Pain: Promising Signal, Weak Evidence Base
Medical cannabis orthopedic pain is a growing area of patient interest despite limited high-quality evidence. This review highlights promising signals for musculoskeletal conditions but notes weak study designs. Clinicians should consider cannabis as…
Are medical cannabis patients finally finding lasting relief from migraines? New research shows …
Migraine affects over 1 billion people globally and is a common reason patients seek cannabis treatment. Cannabis efficacy migraine management remains under study with emerging evidence. This research highlights the importance of clinical evaluation for…
Review Finds Limited Evidence for Cannabis in Treating Mental Health Disorders
A recent review highlights limited evidence cannabis mental health benefits for conditions like PTSD and anxiety. The study emphasizes the need for more rigorous research. Clinicians should consider cannabis as adjunctive, not primary, therapy.
New Study Highlights Potential of Non-Intoxicating Cannabis Compounds CBD and CBG
This article reviews a new study on non-intoxicating cannabis compounds, focusing on CBD and CBG. The research highlights clinical relevance but lacks full methodological details. Clinicians should await peer-reviewed evidence before applying findings.
Research News Roundup: April 2, 2026 – Partnership to End Addiction
The 2026 cannabis addiction research update presents emerging clinical findings and evidence quality assessments. This roundup emphasizes addiction treatment research methodology. Clinicians should review these updates to inform clinical practice.
